{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:08:45Z","timestamp":1794956925663,"version":"4.9.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"GILS"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate clinical associations of anti-PM\/Scl antibodies in patients with SSc in a multicentre international cohort, with particular focus on unresolved issues, including scleroderma renal crisis (RC), malignancies, and functional outcome of interstitial lung disease (ILD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>(1) Analysis of SSc patients from the EUSTAR database: 144 anti-PM\/Scl+ without SSc-specific autoantibodies were compared with 7202 anti-PM\/Scl\u2212, and then to 155 anti-Pm\/Scl+ with SSc-specific antibodies. (2) Case\u2013control study: additional data were collected for 165 anti-PM\/Scl+ SSc patients (85 from the EUSTAR registry) and compared with 257 anti-PM\/Scl\u2212 SSc controls, matched for sex, cutaneous subset, disease duration and age at SSc onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with isolated anti-PM\/Scl+, as compared with anti-Pm\/Scl\u2212, had higher frequency of muscle involvement, ILD, calcinosis and cutaneous signs of DM, but similar frequency of SRC and malignancies (either synchronous with SSc onset or not). The presence of muscle involvement was associated with a more severe disease phenotype. Although very frequent, ILD had a better functional outcome in cases than in controls. In patients with both anti-PM\/Scl and SSc-specific antibodies, a higher frequency of typical SSc features than in those with isolated anti-PM\/Scl was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The analysis of the largest series of anti-PM\/Scl+ SSc patients so far reported helps to delineate a specific clinical subset with muscle involvement, cutaneous DM, calcinosis and ILD characterized by a good functional outcome. SRC and malignancies do not seem to be part of this syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab152","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T16:29:48Z","timestamp":1613060988000},"page":"5028-5041","source":"Crossref","is-referenced-by-count":68,"title":["The clinical phenotype of systemic sclerosis patients with anti-PM\/Scl antibodies: results from the EUSTAR cohort"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-6866","authenticated-orcid":false,"given":"Maria-Grazia","family":"Lazzaroni","sequence":"first","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia"},{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8093-2734","authenticated-orcid":false,"given":"Emiliano","family":"Marasco","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Istituto di Ricovero e Cura a Carattere Scientifico\u00a0Policlinico S. Matteo Foundation of Pavia, University of Pavia, Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3794","authenticated-orcid":false,"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Istituto di Ricovero e Cura a Carattere Scientifico\u00a0San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy"},{"name":"Royal Free Hospital and University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska","family":"DeVries-Bouwstra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat-Ixchel","family":"Gonzalez-Perez","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease and Rheumatology Units, Instituto Nacional de Enfermedades Respiratorias, Ismael Cos\u00edo Villegas, M\u00e9xico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Serrano","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease and Rheumatology Units, Instituto Nacional de Enfermedades Respiratorias, Ismael Cos\u00edo Villegas, M\u00e9xico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Lille Nord-de-France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zanatta","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine, University of Padova, Padova"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-4505","authenticated-orcid":false,"given":"Simone","family":"Barsotti","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Furini","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa Complessa\u00a0Reumatologia, Azienda Ospedaliero Universitaria S. Anna, University of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-2636","authenticated-orcid":false,"given":"Konstantinos","family":"Triantafyllias","sequence":"additional","affiliation":[{"name":"ACURA Centre for Rheumatic Diseases, Bad Kreuznach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-0133","authenticated-orcid":false,"given":"Giuseppina","family":"Abignano","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine and National Institute for Health Research\u00a0Biomedical Research Centre, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and ImmunoConcept, University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"De Luca","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Istituto di Ricovero e Cura a Carattere Scientifico\u00a0San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hesselstrand","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1273","authenticated-orcid":false,"given":"Francesca","family":"Ingegnoli","sequence":"additional","affiliation":[{"name":"Division of Clinical Rheumatology, Department of Clinical Sciences and Community Health, Research Centre for Adult and Paediatric Rheumatic Diseases, ASST Pini-Centro Traumatologico Ortopedico, Universit\u00e0 Degli Studi di Milano, Milano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Bertoldo","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Azienda Ospedaliero Universitaria Integrata, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[{"name":"Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bellando-Randone","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Division of Rheumatology AOUC and Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Poormoghim","sequence":"additional","affiliation":[{"name":"Scleroderma Study Group, Department of Rheumatology, Firoozgar Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colombo","sequence":"additional","affiliation":[{"name":"University of Sassari, Sassari"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Centre, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Furloni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Zingarelli","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia"},{"name":"Department of Clinical and Experimental Sciences, University of Brescia, Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine and National Institute for Health Research\u00a0Biomedical Research Centre, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Royal Free Hospital and University College London Medical School, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Hospital Istituto di Ricovero e Cura a Carattere Scientifico\u00a0Policlinico S. Matteo Foundation of Pavia, University of Pavia, Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Paris, Cochin Hospital and Institut national de la sant\u00e9 et de la recherche m\u00e9dicale\u00a0U1016, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the EUSTAR co-authors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"2021110402581339100_keab152-B1","article-title":"Pathogenic roles of autoantibodies in systemic sclerosis: current understandings in pathogenesis","author":"Sen\u00e9cal","journal-title":"J Scleroderma Relat Disord"},{"key":"2021110402581339100_keab152-B2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"2021110402581339100_keab152-B4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"2021110402581339100_keab152-B5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2021110402581339100_keab152-B6","first-page":"S12","article-title":"Anti-PM-Scl antibody in patients with systemic sclerosis","volume":"30","author":"Koschik","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2021110402581339100_keab152-B7","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021110402581339100_keab152-B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.semarthrit.2014.07.002","article-title":"Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM\/Scl antibody","volume":"44","author":"Guillen-Del Castillo","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2021110402581339100_keab152-B9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/08916934.2015.1077231","article-title":"Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects","volume":"48","author":"Wodkowski","year":"2015","journal-title":"Autoimmunity"},{"key":"2021110402581339100_keab152-B10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.38428","article-title":"Clinical and serologic correlates of anti-PM\/scl antibodies in systemic sclerosis: a multicenter study of 763 patients","volume":"66","author":"D'Aoust","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B11","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"2021110402581339100_keab152-B12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/kew382","article-title":"Resolution of paraneoplastic PM\/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour","volume":"56","author":"Bruni","year":"2017","journal-title":"Rheumatology (Oxford"},{"key":"2021110402581339100_keab152-B13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021110402581339100_keab152-B14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"2021110402581339100_keab152-B15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/art.38928","article-title":"Cancer-induced autoimmunity in the rheumatic diseases","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J Rheumatol"},{"key":"2021110402581339100_keab152-B17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2397198318786158","article-title":"Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: why and how to screen","volume":"3","author":"Lazzaroni","year":"2018","journal-title":"J Scleroderma Relat Disorders"},{"key":"2021110402581339100_keab152-B18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/art.40065","article-title":"Anti-RNPC3 antibodies as a marker of cancer-associated scleroderma","volume":"69","author":"Shah","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B19","article-title":"Advances at the interface of cancer and systemic sclerosis","author":"Mecoli","year":"2020","journal-title":"J Scleroderma Rel Disorders"},{"key":"2021110402581339100_keab152-B20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-015-0181-x","article-title":"Exosomes in cancer: small particle, big player","volume":"8","author":"Zhang","year":"2015","journal-title":"J Hematol Oncol"},{"key":"2021110402581339100_keab152-B21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","journal-title":"Am Heart J"},{"key":"2021110402581339100_keab152-B22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021110402581339100_keab152-B23","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021110402581339100_keab152-B24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2021110402581339100_keab152-B25","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021110402581339100_keab152-B26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B27","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3899\/jrheum.101248","article-title":"Clinical and serological hallmarks of systemic sclerosis overlap syndromes","volume":"38","author":"Pakozdi","year":"2011","journal-title":"J Rheumatol"},{"key":"2021110402581339100_keab152-B28","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2021110402581339100_keab152-B29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cca.2010.03.018","article-title":"Anti-PM\/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma","volume":"411","author":"Maes","year":"2010","journal-title":"Clin Chim Acta"},{"key":"2021110402581339100_keab152-B30","first-page":"14","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2021110402581339100_keab152-B31","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/art.39316","article-title":"Interpretation of an extended autoantibody profile in a well characterized Australian systemic sclerosi (scleroderma) cohort using principal components analysis","volume":"67","author":"Patterson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021110402581339100_keab152-B32","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.ejim.2017.07.033","article-title":"Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?","volume":"44","author":"Benyamine","year":"2017","journal-title":"Eur J Intern Med"},{"key":"2021110402581339100_keab152-B33","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2021110402581339100_keab152-B34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis\u2014a EUSTAR analysis","volume":"22","author":"B\u00fctikofer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2021110402581339100_keab152-B35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021110402581339100_keab152-B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"2021110402581339100_keab152-B37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-015-0573-x","article-title":"Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma","volume":"17","author":"Muro","year":"2015","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab152\/37415804\/keab152.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5028\/41073379\/keab152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/11\/5028\/41073379\/keab152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T23:02:21Z","timestamp":1635980541000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/11\/5028\/6134196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,2,12]]},"published-print":{"date-parts":[[2021,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab152","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,2,12]]}}}